Ironwood Pharmaceuticals Inc [NASDAQ: IRWD] stock went on a downward path that fall over -31.48% on Monday, amounting to a one-week price decrease of less than -48.98%.
Over the last 12 months, IRWD stock dropped by -91.91%. The one-year Ironwood Pharmaceuticals Inc stock forecast points to a potential upside of 89.17. The average equity rating for IRWD stock is currently 2.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $104.84 million, with 160.21 million shares outstanding and 156.66 million shares in the current float. Compared to the average trading volume of 3.33M shares, IRWD stock reached a trading volume of 15966493 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Ironwood Pharmaceuticals Inc [IRWD]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IRWD shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IRWD stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Citizens JMP have made an estimate for Ironwood Pharmaceuticals Inc shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on Apr-15-25. While these analysts kept the previous recommendation, Leerink Partners raised their target price to Market Perform. The new note on the price target was released on September 09, 2024, representing the official price target for Ironwood Pharmaceuticals Inc stock. Previously, the target price had yet another drop from $12 to $4, while CapitalOne kept a Equal Weight rating on IRWD stock.
The Average True Range (ATR) for Ironwood Pharmaceuticals Inc is set at 0.15, with the Price to Sales ratio for IRWD stock in the period of the last 12 months amounting to 0.30. Price to Free Cash Flow for IRWD in the course of the last twelve months was 1.01 with Quick ratio for the last quarter at 4.69.
IRWD Stock Performance Analysis:
Ironwood Pharmaceuticals Inc [IRWD] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -48.98. With this latest performance, IRWD shares dropped by -56.52% in over the last four-week period, additionally sinking by -84.61% over the last 6 months – not to mention a drop of -91.91% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for IRWD stock in for the last two-week period is set at 15.33, with the RSI for the last a single of trading hit 9.43, and the three-weeks RSI is set at 20.32 for Ironwood Pharmaceuticals Inc [IRWD]. The present Moving Average for the last 50 days of trading for this stock 1.5700, while it was recorded at 0.9487 for the last single week of trading, and 3.8545 for the last 200 days.
Insight into Ironwood Pharmaceuticals Inc Fundamentals:
Ironwood Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.69 and a Current Ratio set at 4.69.
Ironwood Pharmaceuticals Inc [IRWD] Institutonal Ownership Details
There are presently around $102.44%, or 104.47%% of IRWD stock, in the hands of institutional investors. The top three institutional holders of IRWD stocks are: BLACKROCK INC. with ownership of 22.88 million shares, which is approximately 14.3868%. VANGUARD GROUP INC, holding 21.56 million shares of the stock with an approximate value of $$140.59 million in IRWD stocks shares; and VANGUARD GROUP INC, currently with $$106.86 million in IRWD stock with ownership which is approximately 10.3073%.
